AbbVie | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 1.46B 1.86B 2025-03
Abbott USD 50.83B 1.76B 2025-06
ALKERMES USD 1.62B 113M 2025-06
Amgen USD 7.43B 1.22B 2025-06
AstraZeneca USD 44.72B 3.68B 2025-06
Biogen USD 17.63B 655.3M 2025-06
BioMarin Pharmaceutical USD 6.03B 233.65M 2025-06
Bristol-Myers Squibb USD 17.49B 100M 2025-06
Eisai JPY 828.51B 12.91B 2025-06
Eli Lilly USD 18.27B 2.43B 2025-06
Gilead Sciences USD 19.67B 596M 2025-06
GlaxoSmithKline GBP 14.35B 197M 2025-06
J&J USD 78.11B 6.62B 2025-03
Medtronic USD 48.02B 1.36B 2025-04
Merck USD 49.06B 725M 2025-06
Neurocrine Biosciences USD 2.69B 158.6M 2025-06
Novartis USD 42.05B 3.6B 2025-06
Pacira USD 757.77M 40.77M 2025-06
Perrigo USD 4.47B 108.3M 2025-06
Pfizer USD 88.7B 1.64B 2025-06
Regeneron Pharmaceuticals USD 29.94B 551.3M 2025-06
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 70.28B 3.8B 2025-06
UCB EUR 10.03B 1.08B 2024-12
Ultragenyx Pharmaceutical USD 151.29M 7.04M 2025-06
United Therapeutics USD 7.17B 366.4M 2025-06
Vertex Pharmaceuticals USD 17.18B 679.1M 2025-06
Zoetis USD 4.98B 322M 2025-06


AbbVie Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.